Gait and Balance of Diabetes Type 2 Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Type 2 diabetes is one of the fastest growing public health problems in both developed and developing countries. It is estimated that the number of people with diabetes in the world will double in coming years, from 171 million in 2000 to 366 million in 2030.The role of physiotherapy in diabetic care is to reduce immobilisation effects, to maintain functional capacity and to minimise diabetes-related complications. The physiotherapist also has a role in providing advice about exercise and daily living activities. The fundamental principle of rehabilitation is to improve quality of life while diminishing the health care burden. By reducing the heightened risk of falling, the fall related injuries and the fear of falling one could improve quality of life in diabetic patients and reduce health care costs.
The goal of this study is to investigate the effectiveness of gait and balance training in pre frail subgroup diabetes patients. Our program is based on recommendations of Robertson et al.(2002) and Page et al.(2002) The investigators randomly assign patients in a control group (no treatment) or in a treatment group. The treatment program consists of two group sessions per week over 12 weeks. Patients were encouraged to perform specific home exercises. After this 12-week program, patients were asked to continue their exercises. The effect of the treatment will be evaluated after the treatment program and after a 6-month follow up.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Type 2 |
Other: Physiotherapy |
Phase 2 Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Efficacy of a Specific Physiotherapy Group Treatment on Gait and Balance in Patients With Diabetic Neuropathy |
- Gait parameter: comfortable speed [ Time Frame: Before treatment / After treatment / 6 month follow up ] [ Designated as safety issue: No ]
- Other spatio temporal gait parameters and sagittal movement of lower limb [ Time Frame: Before Treatment/ After Treatment/ 6 month follow up ] [ Designated as safety issue: No ]
- Balance measures (Tinetti and Biodex balance Index, acceleration on sacrum) [ Time Frame: Before Treatment / After Treatment / 6 month follow up ] [ Designated as safety issue: No ]
- Fear of falling (Falls efficacy scale) [ Time Frame: Before Treatment / After Treatment / 6 month follow up ] [ Designated as safety issue: No ]
| Enrollment: | 71 |
| Study Start Date: | September 2007 |
| Study Completion Date: | March 2009 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: A,1
Physiotherapy
|
Other: Physiotherapy
Gait and Balance training based on recommendations of Robertson et al. and Page et al. (different balance control exercises; progression in consecutive stages: Sensimotor training, a static phase, a dynamic phase combined with functional tasks. The treatment takes place twice a week over 12 weeks. Patients were encouraged to perform specific home exercises.
Other Name: Physical Therapy
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Past or present patient from the University Hospital in Geneva
- Diagnosed with diabetes by the medical doctor (glycaemia > 7 mmol on two different tests on an empty stomach)
- Presence of a peripheral neuropathy (vibration perception ≤ 4)
Exclusion Criteria:
- Patients with a foot ulcer at the moment of intake
- Patients with orthopaedic or chirurgical problems influencing gait parameters
- Patients with a non diabetic neuropathy (Charcot, alcohol, Thyroid dysfunction)
- Patients with neurological problems influencing gait parameters
- Patients with incapacity to walk without a walking aid
Contacts and Locations| Switzerland | |
| University Hospital of Geneva | |
| Geneva, Switzerland, 1205 | |
| Principal Investigator: | Lara E Allet, MPtSc | University Hospital and University Geneva |
More Information
Publications:
| Responsible Party: | Lara Allet (Mrs), University Hopsital Geneva |
| ClinicalTrials.gov Identifier: | NCT00637546 History of Changes |
| Other Study ID Numbers: | 06-305 |
| Study First Received: | March 11, 2008 |
| Last Updated: | January 13, 2010 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by University Hospital, Geneva:
|
Treatment Efficacy Diabetes Gait Balance |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Diabetic Neuropathies Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Peripheral Nervous System Diseases Neuromuscular Diseases Nervous System Diseases Diabetes Complications |
ClinicalTrials.gov processed this record on May 16, 2013